BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25564869)

  • 1. Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells.
    Guzzo G; Sciacovelli M; Bernardi P; Rasola A
    Oncotarget; 2014 Dec; 5(23):11897-908. PubMed ID: 25564869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase.
    Sciacovelli M; Guzzo G; Morello V; Frezza C; Zheng L; Nannini N; Calabrese F; Laudiero G; Esposito F; Landriscina M; Defilippi P; Bernardi P; Rasola A
    Cell Metab; 2013 Jun; 17(6):988-999. PubMed ID: 23747254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.
    Masgras I; Ciscato F; Brunati AM; Tibaldi E; Indraccolo S; Curtarello M; Chiara F; Cannino G; Papaleo E; Lambrughi M; Guzzo G; Gambalunga A; Pizzi M; Guzzardo V; Rugge M; Vuljan SE; Calabrese F; Bernardi P; Rasola A
    Cell Rep; 2017 Jan; 18(3):659-672. PubMed ID: 28099845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.
    Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A
    Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819
    [No Abstract]   [Full Text] [Related]  

  • 5. S-nitrosylation of the Mitochondrial Chaperone TRAP1 Sensitizes Hepatocellular Carcinoma Cells to Inhibitors of Succinate Dehydrogenase.
    Rizza S; Montagna C; Cardaci S; Maiani E; Di Giacomo G; Sanchez-Quiles V; Blagoev B; Rasola A; De Zio D; Stamler JS; Cecconi F; Filomeni G
    Cancer Res; 2016 Jul; 76(14):4170-82. PubMed ID: 27216192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAP1 attenuates H9C2 myocardial cell injury induced by extracellular acidification via the inhibition of MPTP opening.
    Zhang L; Liu L; Li X; Zhang X; Zhao J; Luo Y; Guo X; Zhao T
    Int J Mol Med; 2020 Aug; 46(2):663-674. PubMed ID: 32626957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Necrosis Factor Receptor-Associated Protein 1 Protects against Mitochondrial Injury by Preventing High Glucose-Induced mPTP Opening in Diabetes.
    Liu L; Zhang L; Zhao J; Guo X; Luo Y; Hu W; Zhao T
    Oxid Med Cell Longev; 2020; 2020():6431517. PubMed ID: 32215175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells.
    Sisinni L; Maddalena F; Lettini G; Condelli V; Matassa DS; Esposito F; Landriscina M
    Int J Oncol; 2014 Feb; 44(2):573-82. PubMed ID: 24297638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial chaperone tumour necrosis factor receptor-associated protein 1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening.
    Xiang F; Huang YS; Shi XH; Zhang Q
    FEBS J; 2010 Apr; 277(8):1929-38. PubMed ID: 20236315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.
    Landriscina M; Amoroso MR; Piscazzi A; Esposito F
    Gynecol Oncol; 2010 May; 117(2):177-82. PubMed ID: 19942270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.
    Tian X; Ma P; Sui CG; Meng FD; Li Y; Fu LY; Jiang T; Wang Y; Jiang YH
    FEBS J; 2014 Jun; 281(12):2805-19. PubMed ID: 24754231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents.
    Landriscina M; Laudiero G; Maddalena F; Amoroso MR; Piscazzi A; Cozzolino F; Monti M; Garbi C; Fersini A; Pucci P; Esposito F
    Cancer Res; 2010 Aug; 70(16):6577-86. PubMed ID: 20647321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting.
    Masgras I; Laquatra C; Cannino G; Serapian SA; Colombo G; Rasola A
    Semin Cancer Biol; 2021 Nov; 76():45-53. PubMed ID: 34242740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways.
    Agliarulo I; Matassa DS; Amoroso MR; Maddalena F; Sisinni L; Sepe L; Ferrari MC; Arzeni D; Avolio R; Paolella G; Landriscina M; Esposito F
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2570-9. PubMed ID: 26071104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
    Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
    World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.
    Pridgeon JW; Olzmann JA; Chin LS; Li L
    PLoS Biol; 2007 Jul; 5(7):e172. PubMed ID: 17579517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments.
    Li XT; Li YS; Shi ZY; Guo XL
    Life Sci; 2020 Aug; 254():117737. PubMed ID: 32376268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells.
    Ghosh JC; Siegelin MD; Dohi T; Altieri DC
    Cancer Res; 2010 Nov; 70(22):8988-93. PubMed ID: 20978188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.
    Condelli V; Maddalena F; Sisinni L; Lettini G; Matassa DS; Piscazzi A; Palladino G; Amoroso MR; Esposito F; Landriscina M
    Oncotarget; 2015 Sep; 6(26):22298-309. PubMed ID: 26084290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAcylation suppresses TRAP1 activity and promotes mitochondrial respiration.
    Kim S; Backe SJ; Wengert LA; Johnson AE; Isakov RV; Bratslavsky MS; Woodford MR
    Cell Stress Chaperones; 2022 Sep; 27(5):573-585. PubMed ID: 35976490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.